Dr. Martens posts stronger H1 results, but warns about U.S. shipping delays

Dr. Martens logo

Dr. Martens posted a 46 percent rise in interim profits, driven by a recovery in store sales as they reopened after Covid lockdowns, but the company warned that shipping delays in its U.S. business would continue into the next fiscal year.

REGISTER a free Account today to continue reading this article.

SIGN-IN if you are already a subscriber of Shoe Intelligence.

barrier_image_SI

Subscribe today for just €8,36 a week

Your membership benefits:

  • Unlimited access to shoeintelligence.com - all insight, analysis and statistics 24h/day available online
  • Our executive edition of Shoe Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Unlimited access to shoeintelligence.com - all insight, analysis and statistics 24h/day available online
  • Powerful search and access to over 16,500 articles and analyses in the archive
  • Personal library to save articles and track your key content

If you aren’t ready to subscribe now, choose the 30 day trial for 1€. To continue reading this article REGISTER NOW